Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
21.73
Dollar change
+0.16
Percentage change
0.74
%
IndexNDX, S&P 500 P/E32.68 EPS (ttm)0.66 Insider Own17.54% Shs Outstand863.67M Perf Week-2.51%
Market Cap18.74B Forward P/E6.14 EPS next Y3.54 Insider Trans-0.00% Shs Float711.14M Perf Month-2.86%
Income574.00M PEG- EPS next Q0.84 Inst Own60.02% Short Float4.88% Perf Quarter3.57%
Sales142.41B P/S0.13 EPS this Y-18.20% Inst Trans-0.06% Short Ratio2.34 Perf Half Y-18.12%
Book/sh22.60 P/B0.96 EPS next Y8.65% ROA0.60% Short Interest34.67M Perf Year-39.77%
Cash/sh0.91 P/C23.90 EPS next 5Y-4.77% ROE2.86% 52W Range19.68 - 36.58 Perf YTD-16.78%
Dividend Est.1.52 (6.99%) P/FCF- EPS past 5Y- ROI1.15% 52W High-40.60% Beta0.72
Dividend TTM1.69 (7.78%) Quick Ratio0.30 Sales past 5Y1.35% Gross Margin17.21% 52W Low10.39% ATR (14)0.77
Dividend Ex-DateFeb 16, 2024 Current Ratio0.66 EPS Y/Y TTM119.40% Oper. Margin1.29% RSI (14)42.82 Volatility2.31% 3.19%
Employees331000 Debt/Eq1.78 Sales Y/Y TTM7.73% Profit Margin0.40% Recom3.10 Target Price25.06
Option/ShortYes / Yes LT Debt/Eq1.57 EPS Q/Q98.20% Payout- Rel Volume2.12 Prev Close21.57
Sales Surprise5.03% EPS Surprise7.16% Sales Q/Q9.96% EarningsJan 04 BMO Avg Volume14.81M Price21.73
SMA20-3.07% SMA50-8.32% SMA200-14.68% Trades Volume31,392,796 Change0.74%
Date Action Analyst Rating Change Price Target Change
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Nov-22-22Upgrade Cowen Market Perform → Outperform $43 → $54
Nov-18-22Upgrade JP Morgan Neutral → Overweight $42
Feb-24-24 07:55AM
Feb-23-24 05:21AM
01:59AM
Feb-22-24 08:31PM
05:45PM
03:15PM Loading…
03:15PM
03:55AM
Feb-21-24 04:22PM
04:06PM
02:33PM
02:33PM
01:00PM
12:04PM
10:40AM
10:12AM
09:55AM Loading…
09:55AM
09:46AM
09:43AM
09:24AM
09:14AM
09:14AM
08:59AM
06:32AM
05:53AM
05:21AM
Feb-20-24 10:48PM
06:37PM
06:32PM
06:32PM
06:10PM
05:52PM Loading…
05:52PM
05:50PM
05:32PM
05:28PM
05:26PM
03:15PM
Feb-18-24 06:45AM
Feb-17-24 03:00AM
Feb-15-24 12:45PM
01:55AM
Feb-14-24 09:23PM
05:45PM
Feb-13-24 11:30AM
09:00AM
08:02AM
Feb-10-24 11:40AM
Feb-09-24 10:44PM
12:30AM
12:30AM
Feb-08-24 08:19PM
03:38PM
01:30PM
10:50AM
10:21AM
08:30AM
08:21AM
08:10AM
08:07AM
04:40AM
Feb-07-24 07:33PM
06:16PM
05:45PM
Feb-05-24 12:00AM
Feb-04-24 08:42PM
08:42PM
Feb-03-24 08:15AM
Feb-02-24 08:28PM
04:56AM
Jan-31-24 05:45PM
Jan-30-24 06:14PM
06:20AM
Jan-26-24 11:15AM
Jan-25-24 05:14PM
04:49PM
01:57PM
Jan-24-24 12:44PM
09:54AM
05:21AM
05:16AM
Jan-23-24 06:52PM
06:46PM
12:19PM
Jan-22-24 05:39PM
Jan-21-24 11:00AM
11:00AM
10:45AM
06:01AM
Jan-20-24 05:50AM
Jan-19-24 05:45AM
05:30AM
Jan-18-24 07:58PM
Jan-17-24 03:19PM
Jan-16-24 03:45PM
08:00AM
08:00AM
Jan-13-24 09:31AM
07:05AM
Jan-12-24 06:10AM
Jan-11-24 05:40PM
03:05PM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walgreens Boots Alliance, Inc.10% OwnerFeb 07Sale235.414,212,395991,639,90726,277,561Feb 09 07:00 AM
JARRETT VALERIE BDirectorJan 29Buy22.444,45699,9934,456Jan 31 04:11 PM
SCHLICHTING NANCY MDirectorJan 16Sale23.0515,209350,5670Jan 18 04:18 PM
WENTWORTH TIMOTHY CChief Executive OfficerJan 05Buy24.2210,000242,220585,122Jan 08 07:29 AM
Gates Richard P.SVP, Chief Pharmacy OfficerNov 10Sale20.451,00020,45073,929Nov 14 08:22 PM
Walgreens Boots Alliance, Inc.10% OwnerNov 09Sale195.381,279,590249,999,89630,489,956Nov 14 07:15 AM
Walgreens Boots Alliance, Inc.10% OwnerAug 03Sale189.271,320,858250,000,11531,769,546Aug 07 05:48 PM
DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareJun 30Buy28.425,172146,98459,050Jul 05 06:57 PM
Walgreens Boots Alliance, Inc.10% OwnerJun 15Sale181.17275,98450,000,02133,090,404Jun 20 06:03 AM
Walgreens Boots Alliance, Inc.10% OwnerMay 11Sale170.77292,79250,000,09033,366,388May 15 05:18 PM
BREWER ROSALIND GCEOMar 29Buy33.9510,000339,510369,945Mar 31 04:26 PM
Walgreens Boots Alliance, Inc.10% OwnerMar 01Sale30.3015,475,166468,897,53010,771,926Mar 03 04:43 PM